Notably, the two studies showing the anti-tumorigenic function of MALAT1 in GBM relied on established cell lines (SHG139, U87, U251), while the more recent studies highlighting its pro-tumorigenic functions were executed using patient-derived primary GBM cultures [[80], [81], [82]]. The gene discussed is MALAT1; the disease is glioblastoma.